跳至主要内容
临床试验/NCT01305317
NCT01305317已完成不适用

Study of Statins' Effect on Serum IgG, IgA Ang IgM Level in Chronic Hemodialysis Patients

Hormozgan University of Medical Sciences1 个研究点 分布在 1 个国家目标入组 74 人开始时间: 2007年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
74
试验地点
1
主要终点
Serum IgG, IgA and IgM level

研究概览

简要总结

This is double blind randomized controlled trial on the statins effects on serum IgG, IgA and IgM level in chronic hemodialysis patients in Bandarabbas

详细描述

This study is a randomized controlled trial of statins effect on serum IgG, IgA and IgM level on chronic hemodialysis patients in Bandarabbas. The study is carried out in Hormozgan, Iran. Seventy four patient were randomized either to receive atorvastatin in addition of usual treatment or not. The primary outcomes were serum IgG,IgA and IgM level. The secondary outcome was drug side effects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

性别
All
接受健康志愿者

入选标准

  • All chronic hemodialysis patients attending Shahid Mohammadi hospital during the study period
  • Accepting to participate in the study

排除标准

  • Refusing to participate in the study

研究组 & 干预措施

lipitor

Experimental

atorvastatin 20mg daily

干预措施: Lipitor (Drug)

结局指标

主要结局

Serum IgG, IgA and IgM level

时间窗: 6 months

次要结局

  • Drug side effects(6 months)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验